Double Medical Technology Future Growth
Future criteria checks 5/6
Double Medical Technology is forecast to grow earnings and revenue by 85.1% and 30.3% per annum respectively. EPS is expected to grow by 85.3% per annum. Return on equity is forecast to be 15.9% in 3 years.
Key information
85.1%
Earnings growth rate
85.3%
EPS growth rate
Medical Equipment earnings growth | 24.0% |
Revenue growth rate | 30.3% |
Future return on equity | 15.9% |
Analyst coverage | Low |
Last updated | 04 Jan 2024 |
Recent future growth updates
No updates
Recent updates
Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
12/31/2025 | 2,633 | 667 | N/A | 505 | 1 |
12/31/2024 | 2,004 | 498 | N/A | 434 | 1 |
12/31/2023 | 1,515 | 183 | N/A | 245 | 1 |
9/30/2023 | 1,325 | -23 | -198 | 101 | N/A |
6/30/2023 | 1,356 | 6 | -240 | 62 | N/A |
3/31/2023 | 1,394 | 39 | -146 | 138 | N/A |
12/31/2022 | 1,434 | 92 | -157 | 128 | N/A |
9/30/2022 | 1,924 | 432 | 111 | 379 | N/A |
6/30/2022 | 1,976 | 536 | 184 | 454 | N/A |
3/31/2022 | 2,050 | 654 | 248 | 510 | N/A |
1/1/2022 | 1,994 | 673 | 438 | 673 | N/A |
9/30/2021 | 1,782 | 632 | 402 | 608 | N/A |
6/30/2021 | 1,761 | 658 | 446 | 625 | N/A |
3/31/2021 | 1,732 | 647 | 465 | 617 | N/A |
12/31/2020 | 1,587 | 606 | 419 | 556 | N/A |
9/30/2020 | 1,497 | 550 | 246 | 508 | N/A |
6/30/2020 | 1,387 | 522 | 226 | 502 | N/A |
3/31/2020 | 1,270 | 472 | 83 | 393 | N/A |
12/31/2019 | 1,257 | 465 | 115 | 434 | N/A |
9/30/2019 | 1,097 | 431 | 150 | 346 | N/A |
6/30/2019 | 964 | 404 | 139 | 323 | N/A |
3/31/2019 | 835 | 386 | 206 | 342 | N/A |
12/31/2018 | 772 | 371 | 231 | 335 | N/A |
9/30/2018 | 698 | 368 | 261 | 341 | N/A |
6/30/2018 | 670 | 339 | 253 | 309 | N/A |
3/31/2018 | 620 | 308 | 256 | 296 | N/A |
12/31/2017 | 594 | 296 | 277 | 314 | N/A |
9/30/2017 | 560 | 261 | 233 | 268 | N/A |
12/31/2016 | 463 | 219 | N/A | 207 | N/A |
12/31/2015 | 392 | 189 | N/A | 123 | N/A |
12/31/2014 | 299 | 139 | N/A | 151 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: 002901 is forecast to become profitable over the next 3 years, which is considered faster growth than the savings rate (2.9%).
Earnings vs Market: 002901 is forecast to become profitable over the next 3 years, which is considered above average market growth.
High Growth Earnings: 002901 is expected to become profitable in the next 3 years.
Revenue vs Market: 002901's revenue (30.3% per year) is forecast to grow faster than the CN market (14.6% per year).
High Growth Revenue: 002901's revenue (30.3% per year) is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: 002901's Return on Equity is forecast to be low in 3 years time (15.9%).